Protocol Summaries: GSK2636771
| GSK Study ID |
Phase | Title | Status |
|---|---|---|---|
| 115717 | phase 1 | A Phase I/IIa, First Time in Human, open-label dose-escalation study of GSK2636771 in subjects with advanced solid tumors with PTEN deficiency | Recruiting |
Quick Search